maxresorb®

BRIEF PROFILE
reg.: n/a
register now
⇒ profile ⇒ full
01 application oral hard tissue substitute, bone
02 specific synthetic bone
03 company botiss biomaterials GmbH
04 illustration
05 material 60% hydoxyapatite, 40% beta-tricalcium phosphate
06 year of introduction n/a
07 approvals X CE-Label n/a FDA-approval
n/a double-blind test n/a prospective randomized controlled clinical study
n/a other
08 last update 2017-02-21

this page is not approved by the provider

Information given here are checked thoroughly by “Implant-Register”. However we can not guarantee for any material or properties. Ask the manufacturer for such questions and give us the information to improve the Register.